°æÇÇ ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå º¸°í¼­ : ±â¼ú, ¿ëµµ, Áö¿ªº°(2025-2033³â)
Transdermal Drug Delivery Systems Market Report by Technology, Application, and Region 2025-2033
»óǰÄÚµå : 1820079
¸®¼­Ä¡»ç : IMARC
¹ßÇàÀÏ : 2025³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 139 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,249,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ® µîÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,666,000
PDF & Excel (5 User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ Copy&Paste°¡ ºÒ°¡´ÉÇÕ´Ï´Ù. Àμâ´Â 5ºÎ±îÁö °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,084,000
PDF & Excel (Corporate License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ Copy&Paste°¡ ºÒ°¡´ÉÇÕ´Ï´Ù. Àμâ´Â 5ºÎ±îÁö °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è °æÇÇ ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â 2024³â 71¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö ½ÃÀå ±Ô¸ð°¡ 115¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025-2033³â 5.22%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ °ÍÀ¸·Î Àü¸ÁÇϰí ÀÖ½À´Ï´Ù. ´ç´¢º´, ½ÉÇ÷°üÁúȯ, ½Å°æÁúȯ µî ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ Áõ°¡ µî ´Ù¾çÇÑ ¿äÀÎÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

°æÇÇ ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå µ¿Çâ:

¸¸¼ºÁúȯ Áõ°¡

»ç¶÷µéÀº ¾É¾Æ¼­ »ýȰÇÏ´Â »ýȰ½À°ü°ú ½Ä½À°ü Àå¾Ö·Î ÀÎÇØ ´ç´¢º´, ½ÉÀ庴, ·ù¸¶Æ¼½º °üÀý¿°, °íÇ÷¾Ð, ½Å°æÁúȯ µî ¸¸¼ºÁúȯ¿¡ °É¸®±â ½±½À´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀ» ¾Î°í Àִ ȯÀÚµéÀº Àå±â°£¿¡ °ÉÃÄ ¾àÀ» º¹¿ëÇØ¾ß Çϱ⠶§¹®¿¡ ½Å·ÚÇÒ ¼ö ÀÖ°í Æí¸®ÇÑ ¾à¹°Àü´Þ ¿É¼ÇÀ» ã¾Æ¾ß ÇÕ´Ï´Ù. °æÇÇÈí¼öÇü ÆÐÄ¡´Â ÀÚÁÖ »ç¿ëÇÒ Çʿ䰡 ¾ø°í ¾à¹°À» ¾ÈÁ¤ÀûÀ¸·Î Áö¼Ó½Ãų ¼ö ÀÖ¾î °¡Àå È¿°úÀûÀÔ´Ï´Ù. ȯÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀÏ ¼ö ÀÖ´Â ºñħ½ÀÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î ´ë¾È¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 °æÇÇ ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. °æÇÇÈí¼öÇü ½Ã½ºÅÛÀ» »ç¿ëÇϴ ȯÀÚ´Â ÁÖ±âÀûÀ¸·Î ÆÐÄ¡¸¦ ºÙÀÌ´Â °Í¸¸À¸·Îµµ º¹¿ë ´©Ãâ °¡´É¼ºÀ» ³·Ãâ ¼ö ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖ´Â »ç¶÷µéÀº º¸´Ù Æí¸®ÇÑ ¼Ö·ç¼ÇÀ» ¿øÇϰí ÀÖ½À´Ï´Ù. ¼¼°è½Å°æÇп¬¸Í(World Federation of Neurology)ÀÇ È¹±âÀûÀÎ »õ·Î¿î ¼¼°è Áúº´ºÎ´ã(Global Burden of Disease : GBD) Á¶»ç¿¡ µû¸£¸é, 2050³â±îÁö ³úÁúȯÀ» ¾Î°í ÀÖ´Â »ç¶÷ÀÇ ¼ö°¡ µÎ ¹è·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

³ëÀÎ Àα¸ Áõ°¡

°í·ÉÈ­ »çȸ¿¡¼­ °æÇÇÅõ¾à ½Ã½ºÅÛ¿¡ ´ëÇÑ ´ÏÁî°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ³ªÀ̰¡ µé¸é ½Å°æÁúȯ, ´ç´¢º´, ·ù¸¶Æ¼½º °üÀý¿°, ½ÉÇ÷°üÁúȯ µî ¿©·¯ ¸¸¼ºÁúȯ¿¡ °É¸± È®·üÀÌ ³ô¾ÆÁý´Ï´Ù. ³ëÀÎÀÇ °æ¿ì, ÀÌ·¯ÇÑ ¾à¹°À» Àå±â°£ ²ÙÁØÈ÷ º¹¿ëÇÏ´Â °ÍÀÌ ¾î·Á¿ï ¼ö ÀÖ½À´Ï´Ù. ³ëÀεéÀÌ ¾àÀ» »ïŰÁö ¸øÇÏ´Â °Íµµ ÀüÇüÀûÀÎ ¹®Á¦ÀÔ´Ï´Ù. °æÇÇ ¾à¹°Àü´Þ ½Ã½ºÅÛÀº °æ±¸¿ë ¾à¹°À» º¹¿ëÇÒ Çʿ並 ÇÇÇÏ°í ºñħ½ÀÀûÀÎ ¾à¹° ¼­¹æÃâ ¹æ¹ýÀ» Á¦°øÇÏ´Â ´É·ÂÀ¸·Î Æí¸®ÇÑ ´ë¾ÈÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ³ëÀÎµé »çÀÌ¿¡¼­ ÇÏ·ç¿¡ ¿©·¯ ¹ø º¹¿ëÇÏ´Â ºÎ´ãÀ» ´ú¾îÁÖ´Â ´õ °£´ÜÇÑ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, °æÇÇ ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå Àü¸ÁÀº ¾çÈ£ÇÕ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)´Â 2050³â±îÁö 80¼¼ ÀÌ»ó ³ëÀÎ Àα¸°¡ 4¾ï 2,600¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù.

³ô¾ÆÁö´Â ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ

Áß±¹ ±¹°¡¾àǰ°¨µ¶°ü¸®±¹(NMPA)Àº 2023³â 10¿ù 31ÀÏ, ·ç¿¹Á¦¾à±×·ìÀÇ ½Å¾à ¸®¹Ù½ºÆ¼±×¹Î ÁÖ 2ȸ °æÇÇÈí¼öÇü ÆÐÄ¡¸¦ °æÁõ¿¡¼­ Áߵ ¾ËÃ÷ÇÏÀ̸Ӻ´(AD)ÀÇ Áõ»ó Ä¡·áÁ¦·Î ½ÂÀÎÇß½À´Ï´Ù. ±ÔÁ¦ ´ç±¹Àº º¸´Ù ±¤¹üÀ§ÇÑ °æÇÇÈí¼öÇü Á¦Á¦¸¦ ½ÂÀÎÇϰí ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â È£¸£¸ó º¸Ãæ, ÅëÁõ ¿ÏÈ­, ¿¹¹æÁ¢Á¾ µî ´Ù¾çÇÑ ÀǾàǰ ¿ëµµÀÇ ÆÐÄ¡°¡ Æ÷ÇԵ˴ϴÙ. °æÇǽýºÅÛÀÌ ´õ ³Î¸® º¸±ÞµÇ°í Á¾·ù°¡ ´Ù¾çÇØÁö¸é¼­ ´õ ¸¹Àº ȯÀÚ¿Í ÀÇ·á Àü¹®°¡¸¦ ²ø¾îµéÀ̰í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

Á¦5Àå ¼¼°èÀÇ °æÇÇ ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå

Á¦6Àå ½ÃÀå ³»¿ª : ±â¼úº°

Á¦7Àå ½ÃÀå ³»¿ª : ¿ëµµº°

Á¦8Àå ½ÃÀå ³»¿ª : Áö¿ªº°

Á¦9Àå SWOT ºÐ¼®

Á¦10Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦11Àå Porter's Five Forces ºÐ¼®

Á¦12Àå °¡°Ý ºÐ¼®

Á¦13Àå °æÀï ±¸µµ

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global transdermal drug delivery systems market size reached USD 7.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.5 Billion by 2033, exhibiting a growth rate (CAGR) of 5.22% during 2025-2033. There are various factors that are driving the market, which include the growing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and neurological disorders, rising geriatric population, and increasing regulatory approvals.

Transdermal Drug Delivery Systems Market Trends:

Growing Prevalence of Chronic Diseases

People are becoming prone to chronic illnesses like diabetes, heart disease, rheumatoid arthritis, hypertension, and neurological disorders because of sedentary lifestyles and poor eating habits. Patients with these disorders need to take medication continuously for a longer time, which prompts them to look for reliable and convenient drug delivery options. For this, transdermal patches work best as they provide a steady flow of medication throughout time without requiring frequent use. The rising demand for non-invasive and easy-to-use alternative that can enhance patient compliance is impelling the transdermal drug delivery systems market growth. Patients using transdermal systems just need to apply a patch on a regular basis, which helps to lower the possibility of missing doses. People with chronic diseases are looking for solutions that offer enhanced convenience. According to the World Federation of Neurology, a groundbreaking new Global Burden of Disease (GBD) study shows that the number of people living with brain disease is expected to double by 2050.

Increasing Geriatric Population

The market is expanding as a result of the growing need for transdermal medication delivery systems among the aging population. People frequently acquire several chronic illnesses as they get older, including neurological disorders, diabetes, rheumatoid arthritis, and cardiovascular ailments. It might be difficult for elderly individuals to take these medications consistently over an extended period. The inability of the elderly to swallow medications is another typical problem. Transdermal drug delivery systems offer a convenient alternative because of their ability to bypass the need to take oral medications and provide a non-invasive method for sustained drug release. Furthermore, the growing need for simpler solutions among older individuals that lowers the burden of multiple daily doses is offering a favorable transdermal drug delivery systems market outlook. The World Health Organization (WHO) claims that the number of people aged 80 years or older is expected to reach 426 million by 2050.

Rising Regulatory Approvals

The National Medical Products Administration (NMPA) of China approved Luye Pharma Group's novel medicine, Rivastigmine Twice Weekly Transdermal Patch, on October 31, 2023, for the symptomatic treatment of mild to moderate Alzheimer's disease (AD). Regulatory agencies are increasingly approving a broader range of transdermal products. This covers patches for a range of medicinal applications such as hormone replacement, pain relief, and even immunizations. Transdermal systems are becoming more widely available and varied, which is drawing in more patients and healthcare professionals.

Transdermal Drug Delivery Systems Market Segmentation:

Breakup by Technology:

Iontophoresis accounts for the majority of the market share

Iontophoresis uses a small electric current to improve the diffusion of drugs via the skin. It is favored because of its ability to deliver precise dosages of medication while lowering side effects. It is especially useful for pain management, localized treatment, and systemic drug delivery, making it a leading choice in the transdermal market. It is non-invasive approach, which makes it a preferable alternative for patients who wish to avoid injections or oral medications, especially when long-term or frequent drug administration is required.

Breakup by Application:

Pain management holds the largest share of the industry

The rising focus on pain management among individuals is contributing to the market growth. Transdermal systems provide continuous and controlled release of pain-relieving medications, which is highly beneficial for chronic pain sufferers. This avoids the need for frequent dosing, making it more convenient for patients. Transdermal patches are a non-invasive alternative to oral medications and injections. Transdermal drug delivery systems for pain management provide an opioid-sparing alternative by delivering low and sustained doses that can manage pain effectively while reducing abuse potential.

Breakup by Region:

North America leads the market, accounting for the largest transdermal drug delivery systems market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for transdermal drug delivery systems.

North America has a well-established healthcare system with access to cutting-edge medical technologies. Patients and healthcare providers in the region are more likely to adopt advanced drug delivery systems owing to the availability of infrastructure that supports their use and distribution. North America, particularly the United States, faces high prevalence of chronic diseases, requiring long-term and consistent medication management among individuals. Apart from this, the rising geriatric population in the region is bolstering the market growth. The number of Americans aged 65 and older is predicted to reach 80 million in 2040, as reported by the Urban Institute.

Competitive Landscape:

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Transdermal Drug Delivery Systems Market

6 Market Breakup by Technology

7 Market Breakup by Application

8 Market Breakup by Region

9 SWOT Analysis

10 Value Chain Analysis

11 Porters Five Forces Analysis

12 Price Analysis

13 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â